NASDAQ · GDRXTechnologyCloud & Data Processing

GoodRx Holdings, Inc. Class A Common Stock (GDRX)

$3.49−1.69%
Close Nov 3, 2026 · split-adjusted
Nov 2, 2026$3.63▲ 9.82% in range
Nov 3, 2025Low $1.87 · High $3.80Nov 2, 2026
What changed · written from our data
As of Nov 3, 2026

GoodRx Holdings closed at $3.49 on Nov 3, down 1.69%, 8.2% below its 52-week closing high. Volume of 1.1M shares was 1.00× its 20-day average (close to normal).

Split-adjusted performance: +3.9% over one month, +36.3% over six months, +3.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $200.41M, down 1.3% from a year earlier, with a net margin of 4.3%.

Short interest was 3.7M shares at the Oct 15 settlement, down 11.6% from the prior report (5.2% of float, 4.2 days to cover).

Market cap$1.19B341.1M shares
Revenue · quarter$200.4M−1.3% YoY
Diluted EPS$0.02−50.0% YoY
P/E · TTM73.3×P/S 1.5×
Net margin4.3%Gross 89.5%
Dividend yieldNone
52-week range1.87 – 3.80−8.2% from high
Volume1.1M1.00× 20-day avg
Volatility · 60d37.8%Annualised
Short % of float5.2%4.2 days to cover
Net cash-$190.5MCash $296.1M
Next earnings—Not scheduled
Split-adjusted performance
1W +0.3%1M +3.9%3M +6.7%6M +36.3%YTD +28.8%1Y +3.6%3Y −31.7%5Y −92.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Cloud & Data Processing

Percentile among 57 companies (100 = best)

6-month momentum80
Revenue growth21
Net margin65
Value (low P/E)7
Size61

Industry medians: 6-month return −10.4%, revenue growth +5.7%, net margin 2.0%, P/E 22.0×.

Short interest

Details →
Shares short3.7M−11.6% vs prior
Days to cover4.2Settled Oct 15
% of float5.2%
Short vol. 10d39.5%of daily volume

Closest peers by size in Cloud & Data Processing

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
GDRXGoodRx Holdings$3.49−1.69%+36.3%−1.3%4.3%73.3$1.19B
LZLegalZoom.com$6.69−3.46%−0.3%+6.6%2.5%68.0$1.15BCompare
UPWKUpwork$9.93+2.16%−3.7%−8.0%17.1%11.8$1.24BCompare
CLVTClarivate$2.09+25.90%−24.5%−5.5%−45.7%—$1.34BCompare
HAWKHawkEye 360$14.59+6.89%——−8.7%—$1.43BCompare
INODInnodata$41.90+1.40%−8.2%+57.8%15.6%31.0$1.44BCompare
SHAZSharonAI Holdings$23.79+14.65%——−22176.0%—$851.8MCompare
PLTKPlaytika Holding$2.01−0.49%−44.8%+5.0%6.6%—$766.7MCompare
TASKTaskUs$8.32−2.69%+30.2%+5.0%7.1%7.1$762.8MCompare

Quick answers

What does GoodRx Holdings do?
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States.
What is GDRX's market cap?
$1.19B, based on the Nov 3 close of $3.49.
What is GDRX's P/E ratio?
73.3× trailing-twelve-month earnings of $16.25M.
Does GoodRx Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of GDRX is sold short?
3.7M shares, 5.2% of float, as of Oct 15, 2026.
What sector is GDRX in?
Technology, in the Cloud & Data Processing industry.

About GoodRx Holdings

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

HQ: Santa Monica, CA697 employeesListed Sep 23, 2020goodrx.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology